Arthur L Burnett Selected Research

Tadalafil (Cialis)

1/2008	Molecular pharmacotherapeutic targeting of PDE5 for preservation of penile health.
11/2006	Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism.
12/2005	Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).
10/2005	Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials.
7/2005	Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arthur L Burnett Research Topics

Disease

91	Erectile Dysfunction 12/2023 - 05/2003
38	Priapism 01/2024 - 07/2003
25	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 05/2003
22	Sickle Cell Anemia (Hemoglobin S Disease) 01/2024 - 05/2006
13	Infections 03/2024 - 10/2013
8	Hemolysis 01/2024 - 03/2013
8	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2022 - 11/2006
6	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 07/2005
6	Neoplasms (Cancer) 01/2022 - 02/2010
6	Wounds and Injuries (Trauma) 01/2021 - 12/2014
5	Acquired Immunodeficiency Syndrome (AIDS) 08/2023 - 06/2005
5	Penile Induration (Peyronie's Disease) 01/2021 - 01/2012
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2017 - 12/2013
5	Fibrosis (Cirrhosis) 04/2017 - 01/2008
5	Ganglion Cysts (Ganglion) 01/2017 - 02/2006
4	Diabetes Mellitus 04/2021 - 08/2003
3	Bladder Exstrophy (Exstrophy, Bladder) 03/2021 - 10/2013
3	Epispadias 03/2021 - 12/2019
3	Congenital Abnormalities (Deformity) 01/2020 - 01/2012
3	Penile Neoplasms (Penile Cancer) 01/2017 - 12/2013
3	Type 2 Diabetes Mellitus (MODY) 01/2017 - 01/2009
3	Crush Injuries 04/2015 - 06/2007
3	Carcinoma (Carcinomatosis) 05/2014 - 12/2013
3	Hypertension (High Blood Pressure) 06/2013 - 03/2008
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2023 - 11/2006
2	Lower Urinary Tract Symptoms 01/2023 - 01/2022
2	Stress Urinary Incontinence 01/2023 - 12/2013
2	Overactive Urinary Bladder (Overactive Bladder) 09/2022 - 01/2020
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2022 - 09/2008
2	Spinal Cord Injuries (Spinal Cord Injury) 10/2016 - 03/2013
2	Hyperlipidemias (Hyperlipidemia) 12/2015 - 09/2010
2	Papillomavirus Infections 04/2015 - 02/2014
2	Adenocarcinoma 04/2014 - 06/2005
2	Stuttering (Stammering) 03/2013 - 11/2006
2	Ischemia 10/2003 - 02/2003
1	Surgical Wound Infection 03/2024
1	Urinary Tract Infections (Urinary Tract Infection) 03/2024

Drug/Important Bio-Agent (IBA)

24	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2024 - 10/2003
23	Phosphodiesterase 5 InhibitorsIBA 01/2024 - 07/2004
22	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2024 - 07/2004
20	Testosterone (Sustanon)FDA Link 01/2024 - 09/2003
14	Sildenafil Citrate (Viagra)FDA Link 12/2022 - 07/2004
10	indolepropanol phosphate (IPP)IBA 03/2024 - 10/2016
10	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2022 - 06/2003
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2008
7	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2022 - 01/2008
7	AndrogensIBA 01/2021 - 11/2006
6	Hemoglobins (Hemoglobin)IBA 01/2023 - 01/2016
6	Nitric Oxide Synthase (NO Synthase)IBA 01/2022 - 05/2005
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 10/2016
5	LigandsIBA 01/2021 - 05/2005
5	rho-Associated KinasesIBA 04/2017 - 02/2006
5	EnzymesIBA 01/2016 - 10/2003
5	ImmunophilinsIBA 07/2009 - 05/2005
5	Tadalafil (Cialis)FDA Link 01/2008 - 07/2005
4	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 12/2019 - 07/2005
3	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2024 - 11/2012
3	Prostate-Specific Antigen (Semenogelase)IBA 01/2023 - 04/2014
3	Nerve Growth Factors (Neurotrophins)IBA 01/2021 - 06/2015
3	ArginaseIBA 01/2016 - 03/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2015 - 09/2010
3	salicylhydroxamic acid (SHAM)IBA 04/2015 - 02/2004
3	NADP (NADPH)IBA 09/2010 - 01/2008
3	Vardenafil Dihydrochloride (Levitra)FDA Link 01/2008 - 07/2005
2	Soluble Guanylyl CyclaseIBA 01/2024 - 04/2017
2	HaptoglobinsIBA 01/2024 - 01/2022
2	Nitric Oxide DonorsIBA 01/2022 - 11/2016
2	Blood Glucose (Blood Sugar)IBA 04/2021 - 10/2020
2	Adenosine (Adenocard)FDA LinkGeneric 01/2020 - 01/2012
2	Caspase 3 (Caspase-3)IBA 01/2016 - 02/2012
2	Hormones (Hormone)IBA 12/2015 - 07/2011
2	Cyclin-Dependent Kinase Inhibitor p16IBA 04/2015 - 02/2014
2	Sickle HemoglobinIBA 09/2014 - 09/2009
2	Biomarkers (Surrogate Marker)IBA 05/2014 - 01/2009
2	Phosphodiesterase InhibitorsIBA 09/2013 - 02/2009
2	avanafilIBA 06/2013 - 08/2012
2	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 02/2013 - 09/2010
2	Aligeron (AS 2)IBA 05/2012 - 06/2005
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 02/2012 - 06/2003
2	Tacrolimus (Prograf)FDA LinkGeneric 07/2009 - 03/2008
2	GPI 1046IBA 06/2007 - 05/2005
1	AntioxidantsIBA 01/2024
1	HemopexinIBA 01/2024
1	Heme (Haem)IBA 01/2024

Therapy/Procedure

45	Therapeutics 01/2024 - 07/2003
37	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 05/2003
22	Penile Prosthesis (Penile Implants) 03/2024 - 02/2013
10	Penile Implantation 01/2023 - 10/2013
4	Drug Therapy (Chemotherapy) 04/2017 - 02/2005
3	Artificial Urinary Sphincter 01/2023 - 12/2013
3	Contraindications 01/2023 - 10/2014
3	Antibiotic Prophylaxis 01/2023 - 03/2017
3	Phalloplasty 03/2021 - 10/2013
3	Prostheses and Implants (Prosthesis) 01/2021 - 01/2012
3	Castration 05/2012 - 09/2003
2	Free Tissue Flaps 03/2021 - 10/2020
2	Penile Transplantation 08/2018 - 05/2017
2	Lymph Node Excision (Lymph Node Dissection) 04/2017 - 01/2017
2	Operative Time 10/2016 - 12/2013
2	Lasers (Laser) 10/2012 - 11/2011